Search

Search Constraints

You searched for: Author/Creator Sokol Harry investigator.

Search Results

1. A clinical decision support tool may help to optimise vedolizumab therapy in Crohn's disease. Issue 5 (22nd December 2019)

2. Effectiveness and safety of ustekinumab induction therapy for 103 patients with ulcerative colitis: a GETAID multicentre real‐world cohort study. Issue 11 (14th April 2020)

3. Effectiveness and safety of ustekinumab maintenance therapy in 103 patients with ulcerative colitis: a GETAID cohort study. Issue 7 (23rd July 2021)

4. Efficacy and safety of golimumab in Crohn's disease: a French national retrospective study. Issue 11 (13th October 2017)

5. Impact of vedolizumab therapy on extra‐intestinal manifestations in patients with inflammatory bowel disease: a multicentre cohort study nested in the OBSERV‐IBD cohort. Issue 4 (18th December 2017)

6. Male gender, active smoking and previous intestinal resection are risk factors for post‐operative endoscopic recurrence in Crohn's disease: results from a prospective cohort study. Issue 9 (20th August 2018)

7. One‐year effectiveness and safety of vedolizumab therapy for inflammatory bowel disease: a prospective multicentre cohort study. Issue 3 (8th June 2017)

8. Risk of serious infection in healthcare workers with inflammatory bowel disease: a case‐control study of the Groupe d'Etude Thérapeutique des Affections Inflammatoires du tube Digestif (GETAID). Issue 7 (2nd August 2018)

9. Safety of ustekinumab or vedolizumab in pregnant inflammatory bowel disease patients: a multicentre cohort study. Issue 4 (7th December 2020)

10. Safety of ustekinumab or vedolizumab in pregnant inflammatory bowel disease patients: a multicentre cohort study. Issue 4 (7th December 2020)